Skip to search.
 FTSE 100 Up 0.55%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
8.64 Up 0.23(2.68%) 14:39 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:8.41
Open:N/A
Bid:8.20 x 500
Ask:8.60 x 500
1y Target Est:12.50
Beta:2.33
Earnings Date:4 May - 8 May (Est.)
Day's Range:8.39 - 8.78
52wk Range:1.77 - 9.63
Volume:80,404
Avg Vol (3m):1,447,000
Market Cap:825.13m
P/E (ttm):N/A
EPS (ttm):-0.90
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FOLDUp 2.68%825.13m
SHPGDown 0.42%46.69b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):656.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.06
Quarterly EPS Est (Mar-15) :-0.21
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback